PMDA drug package insert
レクビオ皮下注300mgシリンジ
PMDA Prescription drug · ノバルティスファーマ株式会社 · package insert Nov 22, 2023
Key facts
| Brand names | レクビオ皮下注300mgシリンジ |
|---|---|
| Nonproprietary names | インクリシランナトリウム |
| Companies | 製造販売（輸入）／ノバルティスファーマ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 持続型LDLコレステロール低下siRNA製剤 |
| Therapeutic category codes | 872189 |
| YJ codes | 2189403G1029 |
| Approval numbers | 30500AMX00279000 |
| Package insert edition | 第2版 |
| Package insert date | Nov 22, 2023 |
| PMDA document key | 300242_2189403G1029_1 |
| PMDA company code | 300242 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: